CD4 and HIV-1 infection: Given that high responses to V3 have been associated with a lower risk of HIV-1 infection among vaccinees who had low gp120-specific plasma IgA: (OR = 0.49, p = 0.007), we also performed a V3-specific analysis for CD8 and CD4 epitopes.